Background: The incidence of acute lymphoblastic leukemia (ALL) is nearly 20% higher among
INTRODUCTION
Leukemia is characterized by the uncontrolled proliferation of hematopoetic cells in the bone marrow (1) . Acute lymphoblastic leukemia (ALL) is the most common subtype of childhood leukemia, comprising nearly 80% of diagnoses (2) . Strong evidence for increased risk of ALL due to sex, age, race/ethnicity, prenatal exposure to x-rays, therapeutic radiation, and specific genetic syndromes has been established (3) . Direct evidence for inherited genetic susceptibility is demonstrated by the high risk of ALL associated with Bloom's syndrome, neurofibromatosis, ataxia telangiectasia, and constitutional trisomy 21 (3) . Ethnic differences in the risk of ALL are well recognized as the incidence of ALL is nearly 20 % higher among Hispanics than nonHispanic Whites in California (4) . This higher risk is possibly due to an increased prevalence of ALL risk alleles in populations with Native American ancestry, as well as ethnic differences in exposure to environmental risk factors (5-7).
Current evidence suggests that leukemia results from chromosomal alterations and genetic variations that disrupt the normal process of lymphoid progenitor cell differentiation (1) . Around 75% of childhood ALL cases have chromosomal aberrations that can be detected by karyotyping, 4 fluorescent in situ hybridization (FISH) or other molecular techniques (8) . In B-cell precursor ALL, these aberrations include hyperdiploid (>50 chromosomes), hypodiploid (<44 chromosomes), and chromosomal translocations such as 11q23 MLL-AF4, t (12; 21) TEL-AML1, t (1; 19) E2A-PBX1, and t (9; 22) BCR-ABL1 (8, 9) . Hyperdiploid and TEL-AML1 rearranged childhood ALL account for approximately 25% and 22% of the entire childhood ALL populations, respectively (10) . It is known that different cytogenetic subtypes have different disease prognoses, and are suspected to have distinct underlying biological mechanisms (11) .
The first genome-wide association study (GWAS) in childhood ALL was published in 2009 with a focus on Caucasian populations (12, 13) , and subsequent GWA studies in diverse populations have confirmed previous genetic associations and identified new susceptibility loci (5, (14) (15) (16) (17) .
These studies confirmed genetic contributions to childhood ALL susceptibility, and include variation within IKZF1 (7p12.2), ARID5B (10q21.2), CEBPE (14q11.2), CDKN2A (9p21.3), GATA3 (10p14), and BM1-PIP4K2A (10p12. 31-12. 2). However, variants within these loci account for <10% of the overall estimated genetic risk of leukemia (18) .
GWAS are focused on the analysis of single markers, and depending on sample size, may lack statistical power to uncover small effects (odds ratio (OR) <2.0) conferred by most common genetic variants identified, to date, for complex diseases. Some variants may be associated with disease status, but may not reach a stringent genome-wide significance threshold (P=5 x10 -8 ).
Complementary approaches to traditional GWAS analysis have been developed, including pathway-based analysis. In pathway analysis, a group of related genes in the same biological functional pathway are jointly tested for association with a disease of interest (19, 20 (21) In the current study, we applied pathway-based analyses to GWAS data from the California Childhood Leukemia Study (CCLS) among Hispanics, and tested for evidence of biological functions that are significantly enriched in ALL. Furthermore, we compared whether different biological pathways were overrepresented in major leukemia subtypes, including B-cell ALL, hyperdiploid B-ALL and TEL-AML1 ALL. Lastly, we utilized the targeted maximum likelihood estimation (TMLE) method with the least absolute shrinkage and selection operator (LASSO) to identify a list of candidate genes within each significantly enriched pathway in ALL, while accounting in models, for the complex correlation between SNPs.
MATERIALS AND METHODS

Study populations
The CCLS is population-based case control study. Incident cases of newly diagnosed childhood leukemia (age 0-14 years) were rapidly ascertained from major clinical centers in the study area, usually within 72 hours of diagnosis. Cases were initially identified from four (1995) (1996) (1997) (1998) (1999) , and later expanded to nine (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) , hospitals in the San Francisco Bay Area and Central Valley.
For each case, one or two healthy controls were randomly selected from the state birth registry maintained by the Center for Health Statistics of the California Department of Public Health (CDPH), matching on child's age, sex, Hispanic ethnicity (a child was considered Hispanic if either parent self-reported as Hispanic) and maternal race (White, Black, Asian/Pacific Islander, Native American, and other/mixed). A detailed description of control selection in the CCLS has been previously reported (22) . A total of 86% of case subjects determined eligible consented to participate, and 86% of controls subjects participated among those contacted and considered eligible (23) .
Cases and controls were eligible to enter the study if they were under 15 years of age, resided in the study area at the time of diagnosis, had at least one parent who speaks either English or Spanish, and had no prior history of malignancy. The current analysis included 777 Hispanics (323 ALL cases and 454 controls) in the CCLS who enrolled and were interviewed subjects between 1995 and 2008, and for whom archived newborn blood (ANB) spot specimens were available. Detailed cytogenetic classification was described previously (24) . Immunophenotypic and cytogenetic classification were abstracted from children's medical records, and reviewed by a consulting clinical oncologist. Immunophenotype was determined for ALL cases using flow cytometry profiles and those who were positive for CD19 or CD10 (≥20%) were classified as Bcell ALL (25) . Cytogenetic classification was determined by pretreated bone marrow specimens at the time of diagnosis using conventional G-banding or FISH. When extra copies of chromosomes 21 and X were identified by FISH assays, an assignment of high hyperdiploid status (51-67 chromosomes) was made (26) . TEL-AML1 translocations were also identified by FISH assays.
This study was reviewed and approved by the institutional review committees at the University of California Berkeley, the CDPH, and the participating hospitals. Written informed consent was obtained from all parent respondents.
Genotyping and quality control
Samples were genotyped at the Genetic Epidemiology and Genomics Laboratory, School of Public Health, University of California, Berkeley, using the Illumina OmniExpress v1 platform which contains 730,525 markers. Quality control filtering removed SNPs that were not on autosomal chromosomes, were missing in >2% of samples, had minor allele frequency (MAF) of <2% or showed significant deviation from Hardy-Weinberg equilibrium in controls (P < 1 × ). The resulting data set of 634,037 SNPs was then subjected to additional quality control filtering in all samples. We excluded samples for which < 98% of loci were successfully genotyped, samples with discordant sex profiles (birth certificate vs. genetically determined sex) and samples displaying cryptic relatedness (based on identity-by-descent calculations with pi-hat cutoff of 0.15). Ten pairs of duplicate samples were included to assess assay reproducibility, with average concordance >99.99%. The above quality control filtering yielded 777 Hispanic individuals (323 ALL cases and 454 controls) and 634,037 SNPs. To adjust for potential population stratification in study samples, principal component analysis was used as implemented in EIGENSTRAT (27) . For pathway analyses, we selected SNPs that showed marginal associations (P<0.001) with ALL and each ALL disease subtypes (B-cell ALL, hyperdiploid B-ALL, and TEL-AML1 ALL), in models adjusted for age, gender and the first five principal components, using PLINK v1.07. At the significance threshold of 0.001, given our sample size, power was present to detect an OR of 1.7 at a minor allele frequency of 15% for childhood ALL and B-cell ALL; an OR of 2.2 at a minor allele frequency of 15% for hyperdiploid B-ALL; and an OR of 2.7 at a minor allele frequency of 20% for TEL-AML1 ALL.
Therefore, all post-QC SNPs for analysis were first filtered based on these criteria and subsequently mapped to genes if they were located within a genomic region based on National Center for Biotechnology Information's dbSNP browser (build 137).
Pathway analyses
Pathway analyses were performed by WEB-based GEne SeT AnaLysis Toolkit (WebGestalt) (28) and Database for Annotation, Visualization and Integrated Discovery, DAVID V6.7 (29) .
We used three pathway resources for this investigation: the BioCarta pathway database (30), the Kyoto Encyclopedia of Genes and Genomes (KEGG) (31) , and the Gene Ontology (GO) database (32) . Further, we explored two bioinformatics tools to investigate whether different classification methods generated consistent results. We compared two pathway tools that classified genes based on KEGG pathways: Webgestalt ''KEGG'' (28) and DAVID "KEGG" (29) . Second, we investigated two additional pathway classification resources in DAVID: GO and BioCarta databases (30) .
To identify functional categories with significant evidence for enrichment in a gene set, we compared the gene set of interest to all human genes. Pathway tools tested whether the number of genes from each pathway in our list of predicted candidate genes is higher than expected given the number of genes selected from the total number of genes. WebGestalt uses the hypergeometric test to determine significance (28) . In DAVID, evidence for gene-enrichment in annotated pathways are evaluated using a modified Fisher's exact test to test for significance (29) . The Benjamini and Hochberg procedure controlling for the false discovery rate (FDR) was performed for each pathway analysis tool to adjust for multiple comparisons (33) . After identifying the enriched pathways in ALL, SNPs with the most significant P-value for each gene were selected to construct an unweighted genetic risk score for each pathway. We used an additive genetic model and assigned a numerical value for each genotype based on the number of risk alleles for each SNP. The cumulative effect of risk alleles was determined by counting the total number of risk alleles for each individual. A logistic regression model was then used to estimate the cumulative effects of multiple risk alleles within the same functional pathway on the risk of ALL, using SAS 9.2.
Targeted maximum likelihood estimation (TMLE)
To further generate a list of candidate genes within each identified biological pathway, targeted maximum likelihood estimation (TMLE) incorporating LASSO was applied, as implemented in the R package (34, 35) . LASSO can handle massive, highly correlated data and select variables of importance while making predictions. TMLE is based on the general maximum likelihood estimate (MLE) framework and combines it with robust estimation using the efficient influence curve, which measures the influence of one observation on the estimator (34, 35) . TMLE helps reduce the bias for the targeted parameter, and provides formal statistical inference. Details of the TMLE method are explained elsewhere (34, 35) . By incorporating LASSO into TMLE, the approach not only helps with data reduction and candidate gene selection, but also produces robust statistical inference. The method was applied to estimate the effects for SNPs within genes of interest (defined as P <0.001) on disease risk, while accounting for the effects of all other SNPs (defined as P <0.05) within genes in the same biological pathway. Based on the Pvalues estimated from TMLE method, we generated a list of candidate genes for each identified pathway (P <0.05). Individuals with no missing genetic data were included (n= 764). All SNPs were pre-screened: those with correlations less than 0.1 or greater than 0.9 with SNPs of interest were excluded in the model since SNPs that have independent effects or are highly correlated each other could not provide additional information to the model (34, 35) .
RESULTS
Study characteristics of 777 Hispanics (323 cases and 454 controls) are described in Table 1 .
The distributions of sex, age, and race/ethnicity were similar between cases and controls. Since 
each individual for each pathway. The risk of ALL increased as the number of risk alleles increased within each biological pathway (P for trend <0.05) ( Table 3) . For example, the odds of developing childhood ALL significantly increased with each additional risk allele for genes in the focal adhesion pathway (OR=1.96; 95% confidence interval: 1.60-2.41).
After identifying the enriched pathways in ALL, we further prioritized a gene list by applying data reduction and causal inference methods. Based on LASSO and TMLE results, we generated a list of candidate genes for each biological pathway, while accounting for confounding effects of other genes within the same pathway. Table 4 presents an example of TMLE results for the focal adhesion pathway. SNPs within VAV3, COL6A6, and COL5A1 genes have much more significant P-values (P<0.05) while other SNPs are no longer significant, suggesting that the effect of the pathway may be driven by these three genes. By applying the same criteria, important genes for each identified pathways were selected as shown in Table 3 and Supplementary Table S5 . For example, in the axon guidance pathway, variation within UNC5, EPHB1, and PLXNC1 may play a more central role in ALL disease development than other genes (Table 3) . Similarly, in leukocyte transendothelial migration pathway, variation within VAV3, and CTNNA2 showed the strongest evidence of association (Table 3) .
Finally, to compare the outcomes of the different pathway databases, genes were classified into pathways using the Gene Ontology and BioCarta databases for childhood ALL. The only significant BioCarta pathway associated with childhood ALL is the integrin signaling pathway, which is triggered when integrins in the cell membrane bind to extracellular matrix components (Supplementary Table S6 Table S7 ).
The results derived using different pathway tools WebGestalt and DAVID are similar (Supplementary Table S8 ). Overall, we observed consistency between different pathway analysis tools when analyzing the same GWAS dataset.
DISCUSSION
This is the first study to show distinct biological pathways are overrepresented in different leukemia disease subtypes using a pathway analysis approach. We further applied TMLE, incorporating LASSO, to select variants of importance and to provide formal statistical inferences for each significantly enriched pathway in ALL. The results demonstrate that newly developed bioinformatics tools and causal inference methods may illuminate new and biologically relevant pathways and genes to improve current understanding of pathogenesis in childhood leukemia. Our pathway-based association analysis reveals strong connections between leukemia development, immune regulation and cancer-related pathways.
Pathway-based analyses provide a complementary approach to combine the effects of many loci; small contributions to overall disease susceptibility conferred by genes with weakly associated SNPs are otherwise missed by conventional GWAS analysis (19) . By taking into account prior biological knowledge about genes and pathways, we may have a better chance to identify novel genes and biological mechanisms involved in disease pathogenesis (21) . Additionally, as the most associated gene in a pathway might not be the best candidate for therapeutic intervention, (42, 43) . Results from the current study underscore the need to consider specific biological pathways for ALL disease subtypes to further understand the disease etiology. The shared mechanism across different ALL disease subtypes, in this analysis, is focal adhesion, which consists of large protein complexes organized at the basal surface of cells. These proteins are indispensable during development, for maintenance of tissue architecture, and the induction of tissue repair, which have been indicated to involve with tumor formation and progression (43, 44) . Although a direct relationship between focal adhesion and leukemia has not been observed, elevated level of focal adhesion kinase has shown in various cancers, including thyroid, prostate, cervix, and colon cancer (37, 45) . 
In addition to identifying enriched pathways, the study further selected a list of candidate genes that can be used for future targeted sequencing and functional studies to assess the genetic effects on ALL susceptibility. The data reduction algorithm, LASSO, together with causal inference method, TMLE, produce a target list of candidate genes while accounting for the correlation between SNPs. Several genes have been identified through the approach, including COL6A6, (56) . This signaling pathway ultimately activates other genes involved in B cell proliferation and differentiation and regulates the identity and function of epidermal and embryonic stem cells (55) . Enhanced CDK6 expression has also been documented in lymphoma and leukemia (57, 58) .
To our knowledge, this is the first report using pathway based analyses and newly developed causal approaches to analysis of GWAS data of childhood ALL. These identified pathways are presumed to play a role in disease pathogenesis through variations in specific genes that have not Another strength of our study is the detailed information on cytogenetic subtypes, which enables us to show distinct biological mechanisms are involved with different disease subtypes.
Furthermore, we employed the TMLE method to prioritize genes that may serve integral functions for tumor development. All prioritized genes have been previously linked to human malignances but not ALL.
Our results should be interpreted in the context of several limitations. A limitation of the pathway analysis method is the requirement for specification of a P cutoff in defining the list of significantly associated SNPs. Clearly, the choice of this threshold could be arbitrary. We chose a relatively stringent cutoff P < 0.001to enable us to refine the gene sets and focus on SNPs most likely to represent a non-spurious association. Another important limitation of the pathway-based approach is the incomplete biological annotation of the human genome, and the complete functional characterization of many human genes is unknown. Moreover, susceptibility loci in intergenic regions were not included in this study. As a result, when using this approach, only a small portion of the human genome variation can be studied. In particular, the results may favor analyses. We aimed at minimizing this effect by selecting pathways from three commonly used resources.
In conclusion, pathway analysis findings are uniquely and naturally connected to the functional biology underlying childhood leukemia. The identification of cancer-related and inflammatoryrelated pathways supports the power of this methodological framework to highlight pathways with established relevance to childhood leukemia etiology. In addition, the results highlight several strong candidate genes for further investigations. Future studies are needed to confirm and sequence the identified genes in a larger Hispanic childhood leukemia dataset and in other ethnic patient populations. 
VAV3
MAP2K2 RRAS2
Abbreviations: Exp, expected; KEGG, Kyoto Encyclopedia of Genes and Genomes; Obs, observed; OR, odds ratio. SNPs which showed association with childhood ALL (P < 0.001) were included in this study. Of the 187 genes submitted for analysis, 185 were incorporated for analysis using a hypergeometric test to compare the submitted list to a reference of all human genes using WebGestalt v.2 (http://bioinfo.vanderbilt.edu/webgestalt/). The analysis was limited to KEGG pathways where at least two genes were present in the submitted list. The top-10 ranking KEGG pathways are shown. Adjusted P-values were based on correlation for False Discovery Rate (FDR) using Benjamini and Hochberg (BH) procedure. *OR and 95% CI for cumulative effects of SNPs within each pathway on the risk of childhood ALL was calculated using a logistic regression model. **Genes were selected based on the P values from targeted maximum likelihood estimation (TMLE) (P <0.05). 
